Metagenomi, Inc. Common Stock ( MGX) - Key Metrics
MGX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | $0.23 | -$0.54 | -$0.57 | -$0.58 |
| 2025Q1 | $0.11 | -$0.68 | -$0.62 | -$0.62 |
MGX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | -0.69 |
| 2025Q1 | ? | -0.50 |
MGX
Price: $1.20
52 week price:
Earnings Per Share: -2.29 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 50.1 million